09.01.01
Archer Daniels Midland, Decatur, IL, has signed an exclusive licensing agreement for flax lignan technology, which gives ADM an exclusive worldwide right to produce and sell flax lignan complex or purified flax lignan for use as an active ingredient in functional foods, nutraceuticals, pharmaceuticals, animal feed additives and veterinary products. ADM’s agreement is with The Flax Consortium, a research collaboration between Agriculture and Agri-Foods Canada, the Saskatoon Research Centre (AAFC), the University of Saskatchewan Technologies (UST) and Dr. William Clark of the University of Western Ontario and the London Health Sciences Centre. The Flax Consortium was formed in 1995 to extract, purify and study the use of flax lignans, for the prevention and treatment of certain diseases. During the past five years, the Consortium’s research has resulted in a number of process and use patents and patent applications, which have been licensed to ADM.
In other news, ADM has signed a licensing agreement with Lifeline Technologies for phytosterol technology. The proprietary technology has applications for expanded uses of phytosterols and phytostanols in foods and beverages. This worldwide exclusive license for the use of proprietary technology will permit applications in a variety of foods.
In other news, ADM has signed a licensing agreement with Lifeline Technologies for phytosterol technology. The proprietary technology has applications for expanded uses of phytosterols and phytostanols in foods and beverages. This worldwide exclusive license for the use of proprietary technology will permit applications in a variety of foods.